Jeffrey M. Jonas

2021

In 2021, Jeffrey M. Jonas earned a total compensation of $4.1M as Chief Innovation Officer at Sage Therapeutics, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$280,547
Option Awards$1,825,102
Salary$625,000
Stock Awards$1,398,590
Other$17,463
Total$4,146,702

Jonas received $1.8M in option awards, accounting for 44% of the total pay in 2021.

Jonas also received $280.5K in non-equity incentive plan, $625K in salary, $1.4M in stock awards and $17.5K in other compensation.

Rankings

In 2021, Jeffrey M. Jonas' compensation ranked 3,226th out of 12,415 executives tracked by ExecPay. In other words, Jonas earned more than 74.0% of executives.

ClassificationRankingPercentile
All
3,226
out of 12,415
74th
Division
Manufacturing
1,311
out of 5,505
76th
Major group
Chemicals And Allied Products
532
out of 2,375
78th
Industry group
Drugs
472
out of 2,096
78th
Industry
Pharmaceutical Preparations
325
out of 1,546
79th

Pay ratio

Jeffrey M. Jonas' Pay$4,146,702
Median Employee's Pay$308,210
Pay Ratio

13

to 1

In 2021, the annual total compensation of Jeffrey M. Jonas was $4,146,702.

The annual total compensation of the median employee at Sage Therapeutics was $308,210.

The ratio of Jeffrey M. Jonas' pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 28, 2022.

Jonas' colleagues

We found four more compensation records of executives who worked with Jeffrey M. Jonas at Sage Therapeutics in 2021.

2021

Barry Greene

Sage Therapeutics

Chief Executive Officer

2021

Albert Robichaud

Sage Therapeutics

Chief Scientific Officer

2021

Christopher Benecchi

Sage Therapeutics

Chief Commercial Officer

2021

Kimi Iguchi

Sage Therapeutics

Chief Financial Officer

News

You may also like